Skip to Content

Vivitrol Approval History

  • FDA approved: Yes (First approved April 13th, 2006)
  • Brand name: Vivitrol
  • Generic name: naltrexone
  • Dosage form: Long-Acting Injection
  • Previous name: Vivitrex
  • Company: Alkermes, Inc.
  • Treatment for: Alcohol Dependence

Vivitrol (naltrexone) is is an opioid antagonist indicated for the treatment of alcohol dependence and opioid dependence.

Development History and FDA Approval Process for Vivitrol

Oct 13, 2010Approval FDA Approves Vivitrol to Treat Opioid-dependent Patients
Apr 13, 2006Approval Vivitrol Approved - Alkermes Inc. and Cephalon Inc - Treatment for Alcohol Dependence
Feb 17, 2006Alkermes Announces Submission of Complete Response to FDA for Vivitrol New Drug Application
Dec 28, 2005FDA Issues Approvable Letter for Vivitrol (formerly Vivitrex), for the Treatment of Alcohol Dependence
Sep 20, 2005FDA Extends PDUFA Date for Vivitrex to December 30, 2005
May 27, 2005Alkermes Announces Priority Review Granted For Vivitrex (Naltrexone Long-Acting Injection) NDA Submission
Apr  1, 2005Alkermes Announces Submission of New Drug Application for Vivitrex for Treatment of Alcohol Dependence

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.